Zobrazeno 1 - 5
of 5
pro vyhledávání: '"D. I. Lakhin"'
Autor:
A. E. Karateev, Yu. V. Barysheva, Ya. V. Belokon, T. Yu. Bolshakova, Yu. Yu. Grabovetskaya, E. A. Dolzhenkova, L. N. Eliseeva, O. B. Ershova, E. V. Zonova, I. Yu. Chernova, A. O. Isakanova, M. N. Kirpikova, V. T. Komarov, E. V. Kryukova, A. I. Kulikov, D. I. Lakhin, L. A. Levasheva, L. V. Masneva, L. V. Menshikova, Yu. V. Mishina, S. V. Norina, Yu. N. Pashkovsky, A. V. Petrov, A. G. Rusanov, A. V. Sarapulova, K. A. Svodtseva, O. V. Semagina, A. N. Sudakova, S. N. Tkachenko, M. M. Toporkov, S. K. Tutelyan, G. R. Fadienko, O. S. Filonenko, O. P. Fomina, A. S. Chernov
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 82-90 (2020)
A combination of chondroitin and glucosamine is widely used in clinical practice as both a symptomatic and structure-modifying agent for the treatment of osteoarthritis (OA). The emergence of new drugs based on this combination substantially expands
Externí odkaz:
https://doaj.org/article/913187d83c914518970f41838708eadd
Autor:
D. I. Lakhin, L. V. Vasilyeva
Publikováno v:
Медицинский вестник Юга России, Vol 0, Iss 1, Pp 65-69 (2017)
Objective: to assess the impact rizendronate acid on clinical and laboratory flow pattern of osteoarthritis in patients with the metabolic syndrome.Material and methods: the study included 50 patients with osteoarthritis and metabolic syndrome, which
Externí odkaz:
https://doaj.org/article/ad44aad6d7094cda92644d3a410a233f
Autor:
L V Vasilyeva, D I Lakhin
Publikováno v:
Терапевтический архив, Vol 89, Iss 5, Pp 65-68 (2017)
Aim. To estimate clinical and laboratory parameters in patients with osteoarthritis (OA) and in those with OA and metabolic syndrome (MS). Subjects and methods. 164 patients with OA were examined and divided into 2 groups of 82 people: a study group
Externí odkaz:
https://doaj.org/article/faf314a57536470f80c10e04afb6e03f
Autor:
L V, Vasil'eva, D I, Lakhin
Publikováno v:
Advances in gerontology = Uspekhi gerontologii. 23(3)
This article shows observable effects of Artrofoon concerning displays a metabolic syndrome in patients with rheumatoid arthritis. Patients of the basic group received Artrofoon throughout 12 months by 4 tablets a day, thus it was possible to reach a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7e8e003c72c554d017798c18e46d7b5b
https://pubmed.ncbi.nlm.nih.gov/21137220
https://pubmed.ncbi.nlm.nih.gov/21137220
Autor:
L V, Vasil'eva, D I, Lakhin
Publikováno v:
Advances in gerontology = Uspekhi gerontologii. 23(2)
In this work the effects of Atorvastatin (liptonorm) in a dosage of 10 mg/24h during 12 months concerning the basic indicators of a lipid spectrum of blood in the patients with a metabolic syndrome are estimated. We have noticed its positive effect c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::135897874ed2d3581a4c9c5a1a3afe70
https://pubmed.ncbi.nlm.nih.gov/21033384
https://pubmed.ncbi.nlm.nih.gov/21033384